Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery

S Segal, R Narayanan, JT Dalton - Expert Opinion on …, 2006 - Taylor & Francis
Selective androgen receptor modulators (SARMS) bind to the androgen receptor and
demonstrate anabolic activity in a variety of tissues; however, unlike testosterone and other …

Anti-prostate cancer activity of plant-derived bioactive compounds: A review

C Thomas-Charles, H Fennell - Current Molecular Biology Reports, 2019 - Springer
Abstract Purpose of Review Prostate cancer is one of the most common cancers in men and
accounts for about 10% of all new cancer cases in the USA. Despite significant …

Pharmacological options for treatment of hyperandrogenic disorders

P Reismann, I Likó, P Igaz, A Patócs… - Mini Reviews in …, 2009 - ingentaconnect.com
Hyperandrogenic disorders are frequent in women. The most common cause is polycystic
ovary syndrome, a condition found up to 7% in women of reproductive age. The effects of …

Regulators of Androgen Action Resource: a one-stop shop for the comprehensive study of androgen receptor action

AD DePriest, MV Fiandalo, S Schlanger, F Heemers… - Database, 2016 - academic.oup.com
Androgen receptor (AR) is a ligand-activated transcription factor that is the main target for
treatment of non-organ-confined prostate cancer (CaP). Failure of life-prolonging AR …

Design, synthesis, and preclinical characterization of the selective androgen receptor modulator (SARM) RAD140

CP Miller, M Shomali, CR Lyttle… - ACS medicinal …, 2011 - ACS Publications
Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor
Modulator (SARM) RAD140 | ACS Medicinal Chemistry Letters ACS ACS Publications C&EN …

Chemoprevention of prostate cancer by natural agents: Evidence from molecular and epidemiological studies

K Mokbel, U Wazir, K Mokbel - Anticancer research, 2019 - ar.iiarjournals.org
Background/Aim: Prostate cancer is one of the most common cancers in men which remains
a global public health issue. Treatment of prostate cancer is becoming increasingly intensive …

Herb–drug interactions between androgenic Chinese herbal medicines and androgen receptor antagonist on tumor growth: Studies on two xenograft prostate cancer …

ZB Zhang, SP Ip, WCS Cho, ACF Ng, Z Hu… - Phytotherapy …, 2021 - Wiley Online Library
Our previous study revealed that Epimedii Folium (EF) and Codonopsis Radix (CNR)
significantly promoted tumor growth on a subcutaneous mouse model of prostate cancer …

Androgen receptor antagonists: a patent review (2008–2011)

ML Mohler, CC Coss, CB Duke III, SA Patil… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: Androgen receptor (AR) antagonists are predominantly used as chemical
castration to treat prostate cancer (ie, in conjunction with androgen deprivation therapy …

By modulating androgen receptor coactivators, daidzein may act as a phytoandrogen

JJ Chen, HC Chang - The Prostate, 2007 - Wiley Online Library
BACKGROUND To identify the phytoandrogen from phytohormone, we established an
assay to assess the androgenicity of phytoestrogens by using androgen receptor (AR) …

Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer

BJ Long, DN Grigoryev, IP Nnane, Y Liu, YZ Ling… - Cancer research, 2000 - AACR
We have found that in addition to being potent inhibitors of 17α-hydroxylase/C17, 20-lyase
and/or 5α-reductase, some of our novel androgen synthesis inhibitors also interact with the …